TELO
NASDAQ · Pharmaceuticals
Telomir Pharmaceuticals Inc
$1.31
-0.01 (-0.76%)
Open$1.34
Previous Close$1.32
Day High$1.35
Day Low$1.30
52W High$3.10
52W Low$1.05
Volume—
Avg Volume377.8K
Market Cap45.38M
P/E Ratio—
EPS$-0.34
SectorPharmaceuticals
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 9.55M | 10.11M | 8.56M |
| Net Income | 1.76M | 2.03M | 1.53M |
| Profit Margin | 18.4% | 20.1% | 17.9% |
| EBITDA | 2.43M | 2.63M | 2.21M |
| Free Cash Flow | 1.02M | 1.59M | 1.30M |
| Rev Growth | -2.0% | +7.8% | +19.7% |
| Debt/Equity | 0.60 | 0.70 | 0.67 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |